Monthly Archives: January 2011

ACLU Files Its Brief in Myriad – Argues DNA Is A Blueprint Without a Name

On November 30, 2010, the ACLU filed its brief at the Federal Circuit in AMP et al. v. USPTO and Myriad Genetics, Inc. et al. If you have been reading my posts on this suit, you are by now probably … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , | Leave a comment

“Patent Reform Act Of 2011” – Reform Or Regression?

Starting from the premise that legislation can raise the quality of patents, Leahy/Hatch/Grassley are poised to introduce this year’s version of Patent Reform. The proposed reforms are extensive, and most have been debated at length. Although the Summary ends by … Continue reading

Posted in Patent Reform Legislation | Tagged , , , , , , | 1 Comment

Astrazeneca v Apotex – Patent That Label!

I recently had a chance to re-read AstraZeneca LP v. Apotex, Inc., Appeal No. 2009-1381, 1424 (Fed. Cir. Nov. 1, 2010) and realized that it is a virtual case note on how to extend patent term by “patenting the label.” … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , | Leave a comment

Judge Goes Medieval On Spoilating Defendants

This summary of Victor Stanley v. Creative Pipe et al., provided by Ron Schutz of Robins, Kaplan, Miller & Ciresi is a cautionary tale for patent prosecutors served with subpoenas (or about to be). If the appropriate steps are not … Continue reading

Posted in Litigation Issues | Tagged , , , , , , , , , , , | Leave a comment